Email I received on Lung cancer

I haven't read this report yet, but thought I would pass it around. dee
Click Here to view as a web page


Welcome to the Profiler eNews for Small Cell Lung Cancer, a service of NexCura division of Thomson Reuters Healthcare, producers of the Profiler Treatment Option Tools. Our goal is to bring you news and information each month relevant to your fight against cancer. We welcome your comments and suggestions.

Tarceva plus Avastin may boost cancer-free survival
ORLANDO - June 4, 2009 (cancerfacts.com) - Adding erlotinib (Tarceva®) to bevacizumab (Avastin®) for maintenance therapy delays disease progression better than bevacizumab alone, say researchers.

Hormone therapy boosts risk of lung cancer death
ORLANDO - June 2, 2009 (cancerfacts.com) - Women with non-small cell lung cancer who take hormones to ease menopausal symptoms have an increased risk of dying from their cancer than women who don't take hormones, say researchers.

Maintenance therapy for non-small cell lung cancer
ORLANDO - June 3, 2009 (cancerfacts.com) - The use of pemetrexed (Alimta) as maintenance therapy following standard treatment improves overall survival for patients with advanced non-small cell lung cancer (NSCLC), say researchers.


US hospital starts genetic testing for all cancer patients
WASHINGTON, D.C. - June 12, 2009 (VOANews.com) - Gene testing is becoming a significant tool in standard medical care and perhaps most importantly in the search for the perfect drug to target a particular type of cancer.


1. Free: We will not ask you to pay for this service.

2. Private: We will never share your e-mail address with anyone without your permission.

3. Easy: You can modify your registration or unsubscribe by logging in to your NexProfiler tool at any time.

You have received this e-mail as a result of your request for information when you registered with NexCura, Inc. You may unsubscribe from this e-mail notification service at any time by going to the following page: http://www.nexcura.com/EU.asp?

NexCura will not release your e-mail address or other personally identifying information.